Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $307 - $353
6 Added 46.15%
19 $1,000
Q2 2022

Aug 08, 2022

BUY
$51.49 - $81.64 $205 - $326
4 Added 44.44%
13 $1,000
Q1 2022

May 10, 2022

BUY
$60.03 - $76.49 $540 - $688
9 New
9 $1,000
Q4 2021

Feb 11, 2022

SELL
$47.97 - $62.21 $47 - $62
-1 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$54.64 - $61.3 $54 - $61
1 New
1 $0
Q2 2020

Aug 11, 2020

SELL
$30.8 - $52.47 $123,138 - $209,775
-3,998 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $177,471 - $316,824
-6,249 Reduced 60.98%
3,998 $135,000
Q4 2019

Feb 13, 2020

BUY
$36.31 - $46.83 $353,877 - $456,405
9,746 Added 1945.31%
10,247 $464,000
Q3 2019

Oct 17, 2019

SELL
$35.66 - $44.99 $201,764 - $254,553
-5,658 Reduced 91.87%
501 $18,000
Q2 2019

Aug 05, 2019

SELL
$36.57 - $47.97 $2,340 - $3,070
-64 Reduced 1.03%
6,159 $268,000
Q1 2019

Apr 16, 2019

BUY
$36.47 - $42.17 $59,081 - $68,315
1,620 Added 35.19%
6,223 $237,000
Q4 2018

Jan 17, 2019

BUY
$41.31 - $52.16 $185,192 - $233,833
4,483 Added 3735.83%
4,603 $198,000
Q3 2018

Nov 02, 2018

BUY
$32.85 - $52.0 $722 - $1,144
22 Added 22.45%
120 $0
Q1 2018

May 03, 2018

BUY
$29.98 - $46.35 $2,938 - $4,542
98 New
98 $3,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.06B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.